Medication info
Atenel M Extended Release 20/1000 mg

Atenel M Extended Release 20/1000 mg

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›26mg / 1 tabletMetformin Hydrochloride›1000mg / 1 tablet
Manufacturer / importer
Ankuk Pharmaceutical Co., Ltd.
Appearance
Pink, egg-shaped extended-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202202216 · Approved 2022.05.23 · Insurance code 650205880

Summary

Main use
Improvement of blood glucose control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current therapy, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose is adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. In patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's existing metformin dose. In patients switching to this medicine from concomitant therapy with teneligliptin and metformin, treatment with this medicine may be started at the existing doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored, and the dose should be adjusted appropriately. When administered concomitantly with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switched to it from other glucose-lowering agents. Because such a switch may cause changes in blood glucose control, any change in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Ingredients

Manufacturer
Ankuk Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in patients with type 2 diabetes mellitus

View approved original text

This medication assists in improving blood glucose control as an adjunct to diet and exercise in patients with type 2 diabetes who are using Teneligliptin and Metformin together. It is used to effectively support blood glucose management and enhance patient health.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current therapy, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose is adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. In patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's existing metformin dose. In patients switching to this medicine from concomitant therapy with teneligliptin and metformin, treatment with this medicine may be started at the existing doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored, and the dose should be adjusted appropriately. When administered concomitantly with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switched to it from other glucose-lowering agents. Because such a switch may cause changes in blood glucose control, any change in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Precautions

This drug is used for the treatment of diabetes and has the effect of lowering blood glucose. There is a very rare risk of developing a serious condition called lactic acidosis during the use of this medication, so caution is warranted. Lactic acidosis is a dangerous condition characterized by an elevated level of lactate in the blood and acidosis, and it is more likely to occur in patients with decreased renal function or those with severe infections, heart issues, etc. Additionally, hypoglycemic symptoms may occur when used in conjunction with insulin or sulfonylureas, so blood glucose should be checked frequently, and patients should be well-informed about the symptoms of low blood sugar. Patients with moderate to severe renal impairment, severe heart failure, hepatic dysfunction, acute infections or severe trauma, or those in a very poor nutritional state should not use this medication. Patients scheduled to undergo tests using radiologic iodinated contrast media should discontinue taking this medication 48 hours prior to the test and resume only after renal function is confirmed to be normal post-examination. Women who are pregnant or may become pregnant, as well as nursing mothers, should ideally not use this medication. This drug can cause side effects such as gastrointestinal disturbances, hepatic function abnormalities, hypoglycemia, acute pancreatitis, skin rash, etc., and patients should consult a physician immediately if any unusual symptoms occur. Furthermore, it is important to regularly monitor renal function and blood tests during the course of treatment with this medication. Alcohol consumption may increase the risk of lactic acidosis, so patients should avoid drinking alcohol while on this medication. Elderly patients may have decreased renal function, so dosage adjustments and regular testing are necessary. This medication may interact with other diabetes treatments, so patients should inform their physician or pharmacist of any other medications they are taking. Patients due to undergo surgery should stop taking this drug 48 hours before the surgery and resume it only after renal function is confirmed to be normal post-surgery. If any severe abdominal pain, persistent vomiting, difficulty breathing, muscle pain, or weakness occurs while taking this medication, the patient should seek medical help immediately. Finally, this medication is not used in children and adolescents as its safety and efficacy have not been established.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • hypoglycemia
  • constipation
  • intestinal obstruction
  • liver dysfunction
  • interstitial pneumonia
  • bullous pemphigoid
  • acute pancreatitis
  • dizziness
Show 134 more
  • abdominal bloating
  • abdominal discomfort
  • nausea
  • abdominal pain
  • distension
  • stomatitis
  • gastric polyps
  • colon polyps
  • duodenal ulcers
  • gastroesophageal reflux disease
  • diarrhea
  • loss of appetite
  • increased amylase
  • increased lipase
  • elevated AST (GOT)
  • elevated ALT (GPT)
  • elevated GGT
  • elevated ALP
  • proteinuria
  • ketonuria
  • potential hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • elevated CK (CPK)
  • increased serum potassium levels
  • malaise
  • allergic rhinitis
  • elevated serum uric acid
  • peripheral edema
  • herpes zoster
  • limb pain
  • upper abdominal pain
  • gastritis
  • upper respiratory infection
  • tremors
  • headache
  • weakness
  • hunger
  • fatigue
  • facial edema
  • dyspepsia
  • nausea
  • viral upper respiratory infection
  • rhinitis
  • cold sweat
  • diabetic retinopathy
  • vision decline
  • cough
  • pulmonary congestion
  • shortness of breath
  • drug overdose
  • benign prostatic hyperplasia
  • headache
  • diarrhea
  • chronic gastritis
  • irritable bowel syndrome
  • fatigue
  • cerebral infarction
  • hyperglycemia
  • liver biopsy
  • neutropenia
  • abnormal blood sugar
  • increased blood sugar
  • increased blood pressure
  • hepatic coma
  • lumbar spinal canal stenosis
  • intervertebral disc protrusion
  • intervertebral disc disease
  • spinal ligament ossification
  • spinal foraminal stenosis
  • rotator cuff syndrome
  • cataracts
  • depression
  • iliac artery stenosis
  • dizziness
  • benign prostatic hyperplasia
  • knee surgery
  • vomiting
  • gastroenteritis
  • acquired mixed hyperlipidemia
  • hypertriglyceridemia
  • vitamin D deficiency
  • abnormal weight gain
  • essential hypertension
  • orthostatic hypotension
  • white coat hypertension
  • bleeding
  • abnormal sputum
  • toxic hepatitis
  • chronic cholecystitis
  • non-alcoholic fatty liver disease
  • alcoholic liver disease
  • eyelid injury
  • ligament sprain
  • lip injury
  • contusion
  • urticaria
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • hyperparathyroidism
  • coronary artery disease
  • unstable angina
  • angina
  • otalgia
  • iron deficiency anemia
  • food allergy
  • pressure ulcer
  • ovarian cyst
  • vulvar pruritus
  • menopausal symptoms
  • chronic bronchitis
  • nasal turbinate hypertrophy
  • arteriosclerosis
  • hearing loss
  • endolymphatic hydrops
  • increased blood creatinine
  • increased blood urea
  • anemia
  • atrial fibrillation
  • hypothyroidism
  • insomnia
  • benign prostatic hyperplasia
  • uterine pus
  • subcutaneous abscess
  • falls
  • animal bites
  • radius fracture
  • diabetic neuropathy
  • spinal brainstem insufficiency

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to keep out air, at room temperature between 1 degrees and 30 degrees Celsius. Storing it this way helps maintain the effectiveness of the medication and prevents deterioration.

Appearance and packaging

Appearance

Pink, egg-shaped extended-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.